|
11.
|
|
1 p, 361.3 KB |
Author correction : Graphene active sensor arrays for long-term and wireless mapping of wide frequency band epicortical brain activity
/
Garcia Cortadella, Ramon (Institut Català de Nanociència i Nanotecnologia) ;
Schwesig, G. (Ludwig-Maximilians-Universität München. Bernstein Center for Computational Neuroscience Munich) ;
Jeschke, C. (Multi Channel Systems GmbH) ;
Illa, Xavi (Institut de Microelectrònica de Barcelona) ;
Gray, Anna L. (University of Manchester. National Graphene Institute. Nanomedicine Lab) ;
Savage, S. (University of Manchester. National Graphene Institute. Nanomedicine Lab) ;
Stamatidou, E. (University of Manchester. National Graphene Institute. Nanomedicine Lab) ;
Schiessl, I. (University of Manchester. Division of Neuroscience and Experimental Psychology) ;
Masvidal Codina, Eduard (Institut de Microelectrònica de Barcelona) ;
Kostarelos, Kostas (Institut Català de Nanociència i Nanotecnologia) ;
Guimerà Brunet, Anton (Institut de Microelectrònica de Barcelona) ;
Sirota, Anton (Ludwig-Maximilians-Universität München. Bernstein Center for Computational Neuroscience Munich) ;
Garrido, Jose (Institut Català de Nanociència i Nanotecnologia)
The original version of this article included an incorrectly named funding source "Graphene Flagship", and omitted the names of GrapheneCore 2 and GrapheneCore3 as funding sources, from the Acknowledgements. [...]
2021 -  10.1038/s41467-021-23078-z
Nature communications, Vol. 12 (April 2021) , art. 2568
|
|
|
12.
|
|
11 p, 295.5 KB |
Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases : Results of the Cardiovascular in Rheumatology (Carma) Project
/
Valero-Jaimes, Jesús A. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
López-González, Ruth (Hospital Virgen de la Concha (Zamora)) ;
Martín-Martínez, María A. (Sociedad Española de Reumatología) ;
García-Gómez, Carmen (Consorci Sanitari de Terrassa) ;
Sánchez-Alonso, Fernando (Sociedad Española de Reumatología) ;
Sánchez-Costa, Jesús T. (Sociedad Española de Reumatología) ;
González-Juanatey, Carlos (Hospital Universitario Lucus Augusti (Lugo)) ;
Revuelta-Evrad, Eva (Hospital General Universitario de Ciudad Real) ;
Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ;
Fernández-Espartero, Cruz (Hospital Universitario de Móstoles (Madrid)) ;
Pérez-García, Carolina (Hospital del Mar (Barcelona, Catalunya)) ;
Torrente-Segarra, Vicenç (Hospital Comarcal Alt Penedès) ;
Sánchez-Nievas, Ginés (Complejo Hospitalario Universitario de Albacete) ;
Pérez-Sandoval, Trinidad (Complejo Asistencial Universitario de León) ;
Font-Ugalde, Pilar (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
García Vivar, María Luz (Hospital de Basurto (Bilbao, Biscaia)) ;
Aurrecoechea, Elena (Hospital de Sierrallana (Santander)) ;
Maiz-Alonso, Olga (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ;
Valls-García, Ramón (Hospital Universitario de Palamós) ;
Miranda-Filloy, José A. (Hospital Universitario Lucus Augusti (Lugo)) ;
Llorca, Javier (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública) ;
Castañeda, Santos (Instituto de Investigación Hospital Universitario de la Princesa) ;
Gonzalez-Gay, MA (University of the Witwatersrand, Johannesburg, South Africa) ;
Universitat Autònoma de Barcelona
Objective: Since obesity has been associated with a higher inflammatory burden and worse response to therapy in patients with chronic inflammatory rheumatic diseases (CIRD), we aimed to confirm the potential association between body mass index (BMI) and disease activity in a large series of patients with CIRDs included in the Spanish CARdiovascular in rheuMAtology (CARMA) registry. [...]
2021 - 10.3390/jcm10030382
Journal of clinical medicine, Vol. 10 (january 2021)
|
|
|
13.
|
|
13 p, 1.1 MB |
A strategic reflection for the management and implementation of CAR-T therapy in Spain : an expert consensus paper
/
Zozaya, Néboa (Universidad de Las Palmas de Gran Canaria) ;
Villaseca Carmena, Javier (Weber Economía y Salud) ;
Abdalla, Fernando (Weber Economía y Salud) ;
Calleja Hernández, Miguel Ángel (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Díez-Martín, José Luis (Universidad Complutense de Madrid) ;
Estévez, Joaquín (Sociedad Española de Directivos de La Salud) ;
García-Sanz, Ramón (Instituto de Investigación Biomédica de Salamanca) ;
Martínez-López, Joaquín (Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12)) ;
Sierra, Jorge (Institut d'Investigació Biomèdica Sant Pau) ;
Vera, Ruth (Complejo Hospitalario de Navarra) ;
Hidalgo, Álvaro (Universidad de Castilla-La Mancha) ;
Universitat Autònoma de Barcelona
CAR-T cell therapy represents a therapeutic revolution in the prognosis and treatment of patients with certain types of hematological cancer. However, they also pose new challenges in the healthcare, regulatory and financial fields. [...]
2022 - 10.1007/s12094-021-02757-9
Clinical & Translational Oncology, january 2022, p. 1-13
|
|
|
14.
|
|
|
15.
|
|
15 p, 1.8 MB |
COVID-19 infection in adult patients with hematological malignancies : a European Hematology Association Survey (EPICOVIDEHA)
/
Pagano, Livio (Università Cattolica del Sacro Cuore) ;
Salmanton-García, Jon (University of Cologne) ;
Marchesi, Francesco (IRCCS Regina Elena National Cancer Institute) ;
Busca, Alessandro (AOU Citta' Della Salute E Della Scienza) ;
Corradini, Paolo (University of Milan) ;
Hoenigl, Martin (Medical University of Graz) ;
Klimko, Nikolai (North-Western State Medical University Named After Iliá Ilich Méchnikov (Sant Petersburg, Rússia)) ;
Koehler, Philipp (University of Cologne. Faculty of Medicine) ;
Pagliuca, Antonio (King's College Hospital NHS Foundation Trust) ;
Passamonti, Francesco (University of Insubria) ;
Verga, Luisa (Università Milano-Bicocca) ;
Víšek, Benjamin (University Hospital Hradec Kralove (República Txeca)) ;
Ilhan, Osman (Ankara University) ;
Nadali, Gianpaolo (Policlinico Borgo Roma Verona (Verona, Itàlia)) ;
Weinbergerová, Barbora (University Hospital Brno (República Txeca)) ;
Cordoba, Raul (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Marchetti, Monia (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo) ;
Collins, Graham (NIHR Oxford Biomedical Research Centre) ;
Farina, Francesca (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ;
Cattaneo, Chiara (ASST-Spedali Civili) ;
Cabirta, Alba (Hospital Universitari Vall d'Hebron) ;
Gomes da Silva, Maria (Portuguese Institute of Oncology) ;
Itri, Federico (San Luigi Gonzaga Hospital - Orbassano) ;
van Doesum, Jaap A (University Medical Center Groningen) ;
Ledoux, Marie-Pierre (ICANS) ;
Čerňan, Martin (University Hospital Olomouc (Olomouc, República Txeca)) ;
Jakšić, Ozren (University Hospital Dubrava) ;
Duarte, Rafael (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Magliano, Gabriele (ASST Grande Ospedale Metropolitano Niguarda (Milà, Itàlia)) ;
Omrani, Ali S. (Communicable Disease Center, Hamad Medical Corporation) ;
Fracchiolla, Nicola (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Kulasekararaj, Austin (King's College London) ;
Valković, Toni (University of Rijeka. Faculty of Medicine) ;
Poulsen, Christian Bjørn (Zealand University Hospital) ;
Machado, Marina (Hospital General Universitario Gregorio Marañón) ;
Glenthøj, Andreas (University of Copenhagen) ;
Stoma, Igor (Gomel State Medical University) ;
Ráčil, Zdeněk (Institute of Hematology and Blood Transfusion) ;
Piukovics, Klára (University of Szeged. Department of Internal Medicine) ;
Navrátil, Milan (University Hospital Ostrava) ;
Emarah, Ziad (Mansoura University. Oncology Center) ;
Sili, Uluhan (Marmara University) ;
Maertens, Johan (KU Leuven) ;
Blennow, Ola (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Bergantim, Rui (University of Porto) ;
Garcia-Vidal, Carolina (Hospital Clínic i Provincial de Barcelona) ;
Prezioso, Lucia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ;
Guidetti, Anna (Fondazione IRCCS Istituto Nazionale Dei Tumori) ;
del Principe, Maria Ilaria (University of Rome Tor Vergata. Department of Biomedicine and Prevention) ;
Popova, Marina (Pavlov University) ;
De Jonge, Nick (Amsterdam UMC, Location VUmc) ;
Ormazabal-Vélez, Irati (Complejo Hospitalario de Navarra) ;
Fernández, Noemí (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Falces-Romero, Iker (Hospital Universitario La Paz (Madrid)) ;
Cuccaro, Annarosa (Azienda USL Toscana NordOvest (Livorno, Itàlia)) ;
Meers, Stef (AZ Klina) ;
Buquicchio, Caterina (Ematologia Con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy) ;
Antić, Darko (University of Belgrade. Faculty of Medicine) ;
Al-Khabori, Murtadha (Sultan Qaboos University Hospital) ;
García-Sanz, Ramón (IBSAL, Centro de Investigación del Cáncer-IBMCC) ;
Biernat, Monika M. (Wroclaw Medical University) ;
Tisi, Maria Chiara (San Bortolo Hospital. Cell Therapy and Hematology) ;
Sal, Ertan (University of Cologne, Faculty of Medicine and University Hospital Cologne. Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases) ;
Rahimli, Laman (University of Cologne. Faculty of Medicine) ;
Čolović, Natasa (University of Belgrade. Faculty of Medicine) ;
Schönlein, Martin (University Medical Center Hamburg-Eppendorf. Department of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology) ;
Calbacho, Maria (Hospital Universitario 12 de Octubre (Madrid)) ;
Tascini, Carlo (Azienda Sanitaria Universitaria del Friuli Centrale (Udine, Itàlia)) ;
Miranda-Castillo, Carolina (Hospital Universitario Rey Juan Carlos (Madrid)) ;
Khanna, Nina (University Hospital Basel (Basilea, Suïssa)) ;
Méndez, Gustavo-Adolfo (Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina) ;
Petzer, Verena (Medical University of Innsbruck. Department of Hematology and Oncology) ;
Novák, Jan (University Hospital of Královské Vinohrady) ;
Besson, Caroline (Centre Hospitalier de Versailles) ;
Duléry, Rémy (Sorbonne Université) ;
Lamure, Sylvain (Universite de Montpellier. Departement d'Hematologie Clinique) ;
Nucci, Marcio (Federal University of Rio de Janeiro) ;
Zambrotta, Giovanni (Università Milano-Bicocca) ;
Žák, Pavel (University Hospital Hradec Kralove (República Txeca)) ;
Seval, Guldane Cengiz (Ankara University) ;
Bonuomo, Valentina (Policlinico Borgo Roma Verona, Verona, Italy) ;
Mayer, Jiří (University Hospital Brno (República Txeca)) ;
López-García, Alberto (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Sacchi, Maria Vittoria (Azienda Ospedaliera Nazionale SS. Antonio E Biagio E Cesare Arrigo. Hematology and BMT Unit) ;
Booth, Stephen (NIHR Oxford Biomedical Research Centre, Churchill Hospital) ;
Ciceri, Fabio (IRCCS San Raffaele Scientific Institute. Hematology and Bone Marrow Transplantation) ;
Oberti, Margherita (ASST-Spedali Civili) ;
Salvini, Marco (University of Insubria) ;
Izuzquiza, Macarena (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Nunes-Rodrigues, Raquel (Portuguese Institute of Oncology) ;
Ammatuna, Emanuele (University Medical Center Groningen) ;
Obr, Aleš (Palacky University. University Hospital Olomouc) ;
Herbrecht, Raoul (ICANS) ;
Núñez-Martín-Buitrago, Lucía (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Mancini, Valentina (ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy) ;
Shwaylia, Hawraa (National Center for Cancer Care and Research, Hamad Medical Corporation) ;
Sciumè, Mariarita (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) ;
Essame, Jenna (King's College Hospital NHS Foundation Trust) ;
Nygaard, Marietta (Zealand University Hospital) ;
Batinić, Josip (University of Zagreb. Faculty of Medicine) ;
Gonzaga, Yung (Instituto Nacional Do Cancer. Hematology Service) ;
Regalado-Artamendi, Isabel (Hospital General Universitario Gregorio Marañón) ;
Karlsson, Linda Katharina (University of Copenhagen) ;
Shapetska, Maryia (Scientific and Practical Center for Surgery, Transplantology and Hematology (Mins, Bielorússia)) ;
Hanakova, Michaela (Institute of Hematology and Blood Transfusion) ;
El-Ashwah, Shaimaa (Mansoura University. Oncology Center) ;
Borbényi, Zita (University of Szeged. Department of Internal Medicine) ;
Çolak, Gökçe Melis (Marmara University) ;
Nordlander, Anna (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Dragonetti, Giulia (Università Cattolica del Sacro Cuore) ;
Maraglino, Alessio Maria Edoardo (Università Cattolica del Sacro Cuore) ;
Rinaldi, Amelia (U.O. Ematologia E Centro Trapianti Midollo Osseo, Ospedale Maggiore) ;
De Ramón-Sánchez, Cristina (Instituto de Investigación Biomédica de Salamanca) ;
Cornely, Oliver A. (German Centre for Infection Research (DZIF))
Patients with hematological malignancies (HM) are at high risk of mortality from SARS-CoV-2 disease 2019 (COVID-19). A better understanding of risk factors for adverse outcomes may improve clinical management in these patients. [...]
2021 - 10.1186/s13045-021-01177-0
Journal of hematology & oncology, Vol. 14 (october 2021)
|
|
|
16.
|
|
14 p, 1.7 MB |
Generating new fanca-deficient hnscc cell lines by genomic editing recapitulates the cellular phenotypes of fanconi anemia
/
Errazquin, Ricardo (Molecular Oncology Unit. CIEMAT) ;
Sieiro, Esther (Molecular Oncology Unit. CIEMAT) ;
Moreno Sánchez, Pilar (Molecular Oncology Unit. CIEMAT) ;
Ramírez de Haro, Ma. José (Institut d'Investigació Biomèdica Sant Pau) ;
Lorz, Corina (Centro de Investigación Biomédica en Red de Cáncer) ;
Peral, Jorge (Molecular Oncology Unit. CIEMAT) ;
Ortiz, Jessica (Molecular Oncology Unit. CIEMAT) ;
Casado, José A. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Roman-Rodriguez, Francisco J. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Hanenberg, Helmut (Heinrich Heine University) ;
Río, Paula (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Surrallés i Calonge, Jordi (Institut d'Investigació Biomèdica Sant Pau) ;
Segrelles, Carmen (Centro de Investigación Biomédica en Red de Cáncer) ;
Garcia-Escudero, Ramon (Centro de Investigación Biomédica en Red de Cáncer) ;
Universitat Autònoma de Barcelona
Fanconi anemia (FA) patients have an exacerbated risk of head and neck squamous cell carcinoma (HNSCC). Treatment is challenging as FA patients display enhanced toxicity to standard treatments, including radio/chemotherapy. [...]
2021 - 10.3390/genes12040548
Genes, Vol. 12 Núm. 4 (april 2021) , p. 548
|
|
|
17.
|
|
|
18.
|
|
11 p, 805.0 KB |
Bias dependent variability of low-frequency noise in single-layer graphene FETs
/
Mavredakis, Nikolaos (Universitat Autònoma de Barcelona. Departament d'Enginyeria Electrònica) ;
Garcia Cortadella, Ramon (Institut Català de Nanociència i Nanotecnologia) ;
Illa, Xavi (Institut de Microelectrònica de Barcelona) ;
Schaefer, Nathan (Institut Català de Nanociència i Nanotecnologia) ;
Bonaccini Calia, Andrea (Institut Català de Nanociència i Nanotecnologia) ;
Guimerà Brunet, Anton (Institut de Microelectrònica de Barcelona) ;
Garrido, Jose (Institut Català de Nanociència i Nanotecnologia) ;
Jiménez Jiménez, David (Universitat Autònoma de Barcelona. Departament d'Enginyeria Electrònica)
Low-frequency noise (LFN) variability in graphene transistors (GFETs) is for the first time researched in this work under both experimental and theoretical aspects. LFN from an adequate statistical sample of long-channel solution-gated single-layer GFETs is measured in a wide range of operating conditions while a physics-based analytical model is derived that accounts for the bias dependence of LFN variance with remarkable performance. [...]
2020 - 10.1039/d0na00632g
Nanoscale advances, Vol. 2, issue 11 (Nov. 2020) , p. 5450-5460
|
|
|
19.
|
|
13 p, 1.6 MB |
Pembrolizumab as consolidation strategy in patients with multiple myeloma : Results of the GEM-pembresid clinical trial
/
Puig, N. (Centro de Investigación Biomédica en Red de Cáncer) ;
Corchete Sánchez, Luis Antonio (Centro de Investigación Biomédica en Red de Cáncer) ;
Pérez-Morán, J. J. (Centro de Investigación Biomédica en Red de Cáncer) ;
Dávila, J. (Complejo Asistencial de Ávila. Hematology Department) ;
Paíno, T. (Centro de Investigación Biomédica en Red de Cáncer) ;
de la Rubia, Javier (Hospital Universitari Doctor Peset (València)) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Martín-Sánchez, J. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
De Arriba, Felipe (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Bladé Creixenti, Juan (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Blanchard, María Jesús (Hospital Universitario Ramón y Cajal (Madrid)) ;
González-Calle, Verónica (Centro de Investigación Biomédica en Red de Cáncer) ;
García-Sanz, Ramón (Centro de Investigación Biomédica en Red de Cáncer) ;
Paiva, Bruno (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ;
Lahuerta, J. J. (Centro de Investigación Biomédica en Red de Cáncer) ;
San-Miguel, J. F. (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ;
Mateos, M. V. (Centro de Investigación Biomédica en Red de Cáncer) ;
Ocio, E. M. (Instituto de Investigación Sanitaria Valdecilla (Santander, Cantàbria)) ;
Universitat Autònoma de Barcelona
PD1 expression in CD4 and CD8 T cells is increased after treatment in multiple myeloma patients with persistent disease. The GEM-Pembresid trial analyzed the efficacy and safety of pembrolizumab as consolidation in patients achieving at least very good partial response but with persistent measurable disease after first-or second-line treatment. [...]
2020 - 10.3390/cancers12123615
Cancers, Vol. 12 Núm. 12 (december 2020) , p. 1-13
|
|
|
20.
|
|
10 p, 890.7 KB |
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
/
Medina, Alejandro (Hospital Universitario de Salamanca) ;
Puig, N. (Centro de Investigación Biomédica en Red de Cáncer) ;
Flores-Montero, Juan (Centro de Investigación Biomédica en Red de Cáncer) ;
Jimenez, C. (Centro de Investigación Biomédica en Red de Cáncer) ;
Sarasquete, M. Eugenia (Centro de Investigación Biomédica en Red de Cáncer) ;
García-Álvarez, M. (Centro de Investigación Biomédica en Red de Cáncer) ;
Prieto-Conde, Isabel (Centro de Investigación Biomédica en Red de Cáncer) ;
Chillon, C. (Centro de Investigación Biomédica en Red de Cáncer) ;
Alcoceba, Miguel (Centro de Investigación Biomédica en Red de Cáncer) ;
Gutierrez, N. C. (Centro de Investigación Biomédica en Red de Cáncer) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Rosinol, L. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Bladé Creixenti, Juan (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Gironella, Mercedes (Hospital Universitari Vall d'Hebron) ;
Hernandez, M. T. (Hospital Universitario de Canarias (La Laguna)) ;
Gonzalez-Calle, V. (Centro de Investigación Biomédica en Red de Cáncer) ;
Cedena, María Teresa (Universidad Complutense de Madrid) ;
Paiva, Bruno (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ;
San-Miguel, J. (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ;
Lahuerta, J. J. (Universidad Complutense de Madrid) ;
Mateos, M. V. (Centro de Investigación Biomédica en Red de Cáncer) ;
Martínez-López, Joaquín (Universidad Complutense de Madrid) ;
Orfao, Alberto (Centro de Investigación Biomédica en Red de Cáncer) ;
Gonzalez, M (Centro de Investigación Biomédica en Red de Cáncer) ;
García-Sanz, Ramón (Centro de Investigación Biomédica en Red de Cáncer) ;
Universitat Autònoma de Barcelona
Detecting persistent minimal residual disease (MRD) allows the identification of patients with an increased risk of relapse and death. In this study, we have evaluated MRD 3 months after transplantation in 106 myeloma patients using a commercial next-generation sequencing (NGS) strategy (LymphoTrack®), and compared the results with next-generation flow (NGF, EuroFlow). [...]
2020 - 10.1038/s41408-020-00377-0
Blood Cancer Journal, Vol. 10 Núm. 10 (january 2020) , p. 108
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
